Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 133	$ 227
Accounts receivable, net of allowance of $6,059 and $5,837 as of September 30, 2024 and December 31, 2023, respectively	8,770	10,046
Notes receivable	0	2,072
Inventory	3,963	5,753
Prepaid expenses and other current assets	1,636	1,695
Total current assets	14,502	19,793
Property and equipment, net	63,208	67,828
Goodwill	7,347	7,347
Intangible assets, net	9,624	11,001
Right-of-use assets - operating leases	10,865	10,990
Restricted cash	10,163	9,936
Inventory, net of current portion	12,844	16,657
Other long-term assets	287	337
Total assets	128,840	143,889
Current liabilities:
Accounts payable	15,400	14,144
Accrued expenses and other current liabilities	14,466	7,580
Accrued R&D software	0	3,500
Short-term debt - unaffiliated (includes debt measured at fair value of $3,695 at September 30, 2024 and $17,223 at December 31, 2023, respectively)	3,695	19,331
Short-term debt - related parties	38,915	19,909
Deferred revenue	3,693	2,834
Total current liabilities	76,169	67,298
Deferred revenue, net of current portion	2,639	3,186
Acquisition-related contingent consideration	1,606	1,606
Noncurrent lease liabilities - operating	26,451	26,177
Warrant liabilities	4,403	4,359
Deferred income tax liabilities	9	9
Other liabilities	283	294
Total liabilities	111,560	102,929
Commitments and contingencies (Note 9)
Stockholders’ equity
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, none issued and outstanding at September 30, 2024 and December 31, 2023
Common Stock, $0.0001 par value, 730,000,000 shares authorized, 21,984,614 and 19,378,192 issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	2	2
Additional paid-in capital	903,670	882,749
Accumulated other comprehensive loss	(2)
Accumulated deficit	(886,390)	(841,791)
Total stockholders’ equity	17,280	40,960
Total liabilitiesl and stockholders' equity	$ 128,840	$ 143,889